Salivary gland cancers (SGCs) are rare, accounting for less than 5% of all malignancies of
the head and neck region, and are morphologically heterogeneous. The diagnosis is mainly …

Objective Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland
tumor. Although multiple reviews have been published on salivary gland malignancies, it …

Simple Summary Adenoid cystic carcinoma (AdCC) is a rare heterogenous disease, often
difficult to diagnose and prognosticate and, therefore, also challenging to treat optimally. To …

Background The present study characterizes national trends in the utilization of adjuvant
chemotherapy to treat salivary gland malignancies. Methods The National Cancer Database …

Background There is no consensus about effective systemic therapy for salivary gland
carcinomas (sgcs). Our aim was summarized the clinical trials assessing the systemic …

Introduction Human epidermal growth factor receptor 2 (HER2) protein overexpression,
gene amplification, and activating mutations have been identified in a subset of salivary …

Introduction Recurrent or metastatic adenoid cystic carcinoma (ACC) of the head and neck is
rare and highly aggressive. Due to the ineffectiveness of immune checkpoint therapies, this …

Abstract Purpose Salivary Gland cancer (SGC) is a rare and heterogenous group of tumors.
Standard therapeutic options achieve high local but poor distant control rates, especially in …

Background Despite advances in precision medicine, most patients with recurrent or
metastatic salivary gland carcinoma still need conventional chemotherapies, such as the …

Introduction: Due to the rarity and various histological types, a standard chemotherapy
regimen for recurrent or metastatic salivary gland carcinoma (SGC) has not been …